Henry North, Ph.D.

Washington, District of Columbia

Dr. North is currently a Postdoctoral Fellow in the Department of Pharmaceutical Sciences at Howard University College of Pharmacy. Working in the laboratory of X. Simon Wang, Ph.D., his research focuses on Cheminformatics and Molecular Modeling of enaminones for further anticonvulsant studies and gp91 phox inhibitors for the treatment of Parkinson’s disease.

He was trained in the areas of Medicinal and Computational Chemistry and his interests lie in the discovery and drug design of novel anticonvulsant agents. During his doctoral studies, he worked on the synthesis of enaminone derivatives and elucidation of the structure activity relationship (SAR) between them with the aid of X-ray crystallography studies. His current work is a continuation of his Ph.D. studies that enhances the study of enaminones by using in silico computational studies to provide a logical explanation to produce novel compounds for epilepsy. Currently he has experience in several computational chemistry packages including: Schrodinger, Gaussian 03 and R.

During his doctoral studies, Dr. North worked under the tutelage of Kenneth R. Scott, Ph.D. and Pradeep Karla, Ph.D. He was a Teaching Assistant (TA) in the Pharmaceutical Sciences and Pharmaceutical Compounding Laboratory for three years. During the summers, he worked as a Biology and Chemistry instructor with the Center of Excellence.

Dr. North holds a B.S. in Biology from Texas Southern University, an M.S. in Biology from the Texas Southern University, and a Ph.D. in Pharmaceutical Sciences from Howard University. Upon completion of the post-doctoral fellowship, Dr. North plans on becoming an Assistant Professor of Pharmaceutical Sciences in a College of Pharmacy.